Evidence map›Paper›PMID 29230012›Full record

ArticleNature communications2017

Estimation of immune cell content in tumour tissue using single-cell RNA-seq data.

Max Schelker, Sonia Feau, Jinyan Du, Nav Ranu, Edda Klipp, Gavin MacBeath, Birgit Schoeberl, Andreas Raue

Abstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 165 papers.

0numbers the graph read from it
0cells of the map it votes in
165citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

165 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Spatial Profiling Identifies Tumor-Associated Stroma Enrichment and MIF as Potential Immunotherapy Targets in Primary Ewing Sarcomas.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

105 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Max SchelkerMerrimack Pharmaceuticals, Inc., Cambridge, MA, 02139, USA.
Sonia FeauMerrimack Pharmaceuticals, Inc., Cambridge, MA, 02139, USA.
Jinyan DuMerrimack Pharmaceuticals, Inc., Cambridge, MA, 02139, USA.
Nav RanuMerrimack Pharmaceuticals, Inc., Cambridge, MA, 02139, USA.
Edda KlippHumboldt-Universität zu Berlin, Unter den Linden 6, 10099, Berlin, Germany.ORCID http://orcid.org/0000-0002-0567-7075
Gavin MacBeathMerrimack Pharmaceuticals, Inc., Cambridge, MA, 02139, USA.
Birgit SchoeberlMerrimack Pharmaceuticals, Inc., Cambridge, MA, 02139, USA.
Andreas RaueMerrimack Pharmaceuticals, Inc., Cambridge, MA, 02139, USA. araue@merrimack.com.ORCID http://orcid.org/0000-0002-9198-2489

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As interactions between the immune system and tumour cells are governed by a complex network of cell-cell interactions, knowing the specific immune cell composition of a solid tumour may be essential to predict a patient's response to immunotherapy. Here, we analyse in depth how to derive the cellular composition of a solid tumour from bulk gene expression data by mathematical deconvolution, using indication-specific and cell type-specific reference gene expression profiles (RGEPs) from tumour-derived single-cell RNA sequencing data. We demonstrate that tumour-derived RGEPs are essential for the successful deconvolution and that RGEPs from peripheral blood are insufficient. We distinguish nine major cell types, as well as three T cell subtypes. Using the tumour-derived RGEPs, we can estimate the content of many tumours associated immune and stromal cell types, their therapeutically relevant ratios, as well as an improved gene expression profile of the malignant cells.

Indexed as

AlgorithmsCells, CulturedGene Expression ProfilingHumansImmune SystemNeoplasmsSingle-Cell AnalysisStromal CellsTumor Microenvironment

Identifiers

PMID29230012
PMCPMC5725570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.